Maryland passed a life-saving cancer law. Now the state needs to enforce it.

Biomarker testing is effective, cost-efficient and protected by Maryland law, which requires insurance to cover it, writes Erin Dalder-Alpher, who asks why patients like herself have to fight to get coverage, while other states are enforcing their coverage laws.

By: Erin Dalder-Alpher

Outlets: Maryland Matters

Published: May 22, 2026

Words: 700

Last Updated: 1 month, 1 week ago

Body Text Preview

Biomarker testing is quite literally saving my life.

I am one of the lucky ones. I live in a state that, in theory, prioritizes this cutting-edge care. Thanks to a 2023 law, biomarker testing coverage is now required for both state-regulated private insurance and Medicaid in Maryland. But as I have learned through a grueling journey of biopsies and bills, a law on the books is only as good as its enforcement.

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

About

FAQ

Email Us